FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010448637> ?p ?o ?g. }

• W3010448637 endingPage "359" @default.
• W3010448637 startingPage "351" @default.
• W3010448637 abstract "Ruxolitinib improves splenomegaly and other disease-related symptoms in patients with myelofibrosis, but over time, many patients lose this benefit. It is difficult to determine whether this is due to resistance or intolerance to the drug; thus, we have used the more inclusive term of ruxolitinib failure. The survival of patients with myelofibrosis after ruxolitinib failure is poor but varies significantly by the pattern of the failure, underlining the need for a clinically appropriate classification. In this review, we propose diagnostic guidance for early recognition of the pattern of ruxolitinib failure and we recommend treatment options. The most frequent patterns of ruxolitinib failure are loss or failure to obtain a significant reduction in splenomegaly or symptom response, and the development or persistence of clinically significant cytopenias. Ruxolitinib dose modification and other ancillary therapies are sometimes helpful, and splenectomy is a palliative option in selected cases. Stem-cell transplantation is the only curative option for these patterns of failure, but its restricted applicability due to toxicity highlights the importance of ongoing clinical trials in this area. Recent approval of fedratinib by the US Food and Drug Administration provides an alternative option for patients with suboptimal or loss of spleen response. The transformation of myelofibrosis to accelerated or blast phase is an infrequent form of failure with an extremely poor prognosis, whereby patients who are ineligible for transplantation have limited treatment options." @default.
• W3010448637 created "2020-03-13" @default.
• W3010448637 creator A5002524955 @default.
• W3010448637 creator A5008036563 @default.
• W3010448637 creator A5023965566 @default.
• W3010448637 creator A5032477445 @default.
• W3010448637 creator A5037631814 @default.
• W3010448637 creator A5046987520 @default.
• W3010448637 creator A5058235020 @default.
• W3010448637 creator A5066614305 @default.
• W3010448637 creator A5067214379 @default.
• W3010448637 creator A5067675521 @default.
• W3010448637 creator A5090391445 @default.
• W3010448637 date "2020-07-01" @default.
• W3010448637 modified "2023-10-06" @default.
• W3010448637 title "Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group" @default.
• W3010448637 cites W135049235 @default.
• W3010448637 cites W1503482160 @default.
• W3010448637 cites W1534089060 @default.
• W3010448637 cites W1924834505 @default.
• W3010448637 cites W1971888832 @default.
• W3010448637 cites W1993214853 @default.
• W3010448637 cites W1993934088 @default.
• W3010448637 cites W2008136854 @default.
• W3010448637 cites W2010298229 @default.
• W3010448637 cites W2056116861 @default.
• W3010448637 cites W2066567885 @default.
• W3010448637 cites W2087172868 @default.
• W3010448637 cites W2115351357 @default.
• W3010448637 cites W2116043577 @default.
• W3010448637 cites W2121743767 @default.
• W3010448637 cites W2123633897 @default.
• W3010448637 cites W2127559749 @default.
• W3010448637 cites W2142506642 @default.
• W3010448637 cites W2155971057 @default.
• W3010448637 cites W2161021913 @default.
• W3010448637 cites W2176736150 @default.
• W3010448637 cites W2418937816 @default.
• W3010448637 cites W2508456582 @default.
• W3010448637 cites W2521045502 @default.
• W3010448637 cites W2558311129 @default.
• W3010448637 cites W2570291199 @default.
• W3010448637 cites W2589237569 @default.
• W3010448637 cites W2598479043 @default.
• W3010448637 cites W2606755940 @default.
• W3010448637 cites W2622547803 @default.
• W3010448637 cites W2626609447 @default.
• W3010448637 cites W2731573311 @default.
• W3010448637 cites W2754551124 @default.
• W3010448637 cites W2757643721 @default.
• W3010448637 cites W2759277150 @default.
• W3010448637 cites W2760217744 @default.
• W3010448637 cites W2768672347 @default.
• W3010448637 cites W2768722269 @default.
• W3010448637 cites W2769707416 @default.
• W3010448637 cites W2778275419 @default.
• W3010448637 cites W2790425028 @default.
• W3010448637 cites W2791240656 @default.
• W3010448637 cites W2810060832 @default.
• W3010448637 cites W2891311699 @default.
• W3010448637 cites W2891785353 @default.
• W3010448637 cites W2896678815 @default.
• W3010448637 cites W2897373244 @default.
• W3010448637 cites W2907253832 @default.
• W3010448637 cites W2917089748 @default.
• W3010448637 cites W4239749161 @default.
• W3010448637 doi "https://doi.org/10.1200/jop.19.00506" @default.
• W3010448637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7359776" @default.
• W3010448637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32134707" @default.
• W3010448637 hasPublicationYear "2020" @default.
• W3010448637 type Work @default.
• W3010448637 sameAs 3010448637 @default.
• W3010448637 citedByCount "14" @default.
• W3010448637 countsByYear W30104486372020 @default.
• W3010448637 countsByYear W30104486372021 @default.
• W3010448637 countsByYear W30104486372022 @default.
• W3010448637 countsByYear W30104486372023 @default.
• W3010448637 crossrefType "journal-article" @default.
• W3010448637 hasAuthorship W3010448637A5002524955 @default.
• W3010448637 hasAuthorship W3010448637A5008036563 @default.
• W3010448637 hasAuthorship W3010448637A5023965566 @default.
• W3010448637 hasAuthorship W3010448637A5032477445 @default.
• W3010448637 hasAuthorship W3010448637A5037631814 @default.
• W3010448637 hasAuthorship W3010448637A5046987520 @default.
• W3010448637 hasAuthorship W3010448637A5058235020 @default.
• W3010448637 hasAuthorship W3010448637A5066614305 @default.
• W3010448637 hasAuthorship W3010448637A5067214379 @default.
• W3010448637 hasAuthorship W3010448637A5067675521 @default.
• W3010448637 hasAuthorship W3010448637A5090391445 @default.
• W3010448637 hasBestOaLocation W30104486371 @default.
• W3010448637 hasConcept C109159458 @default.
• W3010448637 hasConcept C126322002 @default.
• W3010448637 hasConcept C141071460 @default.
• W3010448637 hasConcept C143998085 @default.
• W3010448637 hasConcept C177713679 @default.
• W3010448637 hasConcept C2776112149 @default.
• W3010448637 hasConcept C2776309230 @default.
• W3010448637 hasConcept C2778080410 @default.

• next